Update: 16.01.2023
Last week: 52 week 2022 (26.12.2022 - 01.01.2023)
Last full month: December 2022
| Time period | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE BERLIN-CHEMIE | |||||||||
| WoW | 154 914 | -18.7% | 2.8% | 0 | 39 698 298 | -15.8% | 3.3% | 0 | -17.7% |
| MoM | 881 320 | 45.7% | 3.1% | -0.2 | 211 916 362 | 53.0% | 3.4% | 0 | 53.3% |
| YTD | 9 846 004 | -25.8% | 4.8% | -1.6 | 2 020 245 630 | -11.8% | 4.7% | -1.1 | -1.1% |
| MAT | 9 846 004 | -26.3% | 4.8% | -1.5 | 2 020 245 630 | -12.4% | 4.7% | -1 | -2.9% |
| DEXALGIN | |||||||||
| WoW | 21 783 | 3.7% | 0.4% | 0 | 10 994 571 | 7.0% | 1.3% | 0.1 | -7.8% |
| MoM | 86 814 | 27.7% | 0.3% | 0 | 42 243 433 | 24.6% | 1.1% | 0 | 29.0% |
| YTD | 1 585 574 | -13.8% | 0.6% | -0.1 | 686 697 189 | -2.0% | 1.7% | -0.2 | 0.2% |
| MAT | 1 585 574 | -15.1% | 0.6% | -0.1 | 686 697 189 | -3.5% | 1.7% | -0.2 | -1.5% |
| ESPUMISAN (ADULTS) | |||||||||
| WoW | 51 375 | -2.1% | 39.0% | -1.6 | 31 278 078 | -0.1% | 48.2% | -0.9 | 2.0% |
| MoM | 241 465 | 0.3% | 41.0% | -0.3 | 141 226 638 | 7.8% | 48.9% | 0.6 | 1.0% |
| YTD | 4 284 062 | -18.9% | 53.1% | -12.8 | 2 208 618 466 | -8.9% | 58.8% | -11.6 | 0.7% |
| MAT | 4 284 062 | -20.1% | 53.1% | -12.8 | 2 208 618 466 | -10.2% | 58.8% | -11.6 | -0.9% |
| ESPUMISAN BABY | |||||||||
| WoW | 21 157 | -3.2% | 30.6% | -0.5 | 15 444 761 | -2.3% | 46.1% | -0.6 | -1.8% |
| MoM | 101 055 | -2.2% | 31.5% | -2.3 | 71 889 362 | 3.5% | 46.8% | -0.7 | 5.1% |
| YTD | 1 426 141 | -14.3% | 36.9% | -4.4 | 905 578 253 | -6.8% | 50.3% | -5.8 | -4.0% |
| MAT | 1 426 141 | -15.8% | 36.9% | -4.4 | 905 578 253 | -8.4% | 50.3% | -5.8 | -5.7% |
| FASTUM | |||||||||
| WoW | 15 047 | 4.8% | 0.9% | 0.1 | 8 573 738 | 5.9% | 2.3% | 0.2 | -6.9% |
| MoM | 67 210 | -6.8% | 0.8% | -0.1 | 38 269 832 | -6.6% | 2.2% | -0.2 | 2.4% |
| YTD | 1 040 568 | -24.9% | 1.1% | -0.4 | 546 361 233 | -14.7% | 2.5% | -0.6 | 0.2% |
| MAT | 1 040 568 | -26.1% | 1.1% | -0.4 | 546 361 233 | -16.0% | 2.5% | -0.7 | -1.2% |
| IODOMARIN | |||||||||
| WoW | 57 914 | -10.2% | 21.6% | -0.4 | 10 670 511 | -9.6% | 8.2% | -0.3 | -8.8% |
| MoM | 292 263 | -2.5% | 21.9% | -1.3 | 53 688 884 | -3.2% | 8.6% | -1.2 | 3.2% |
| YTD | 3 293 381 | 4.0% | 20.6% | 0 | 639 996 905 | 8.0% | 9.1% | -0.3 | 4.2% |
| MAT | 3 293 381 | 3.1% | 20.6% | 0.1 | 639 996 905 | 7.0% | 9.1% | -0.3 | 2.8% |
| LIOTON | |||||||||
| WoW | 14 285 | -1.1% | 1.6% | 0.1 | 17 298 730 | 2.6% | 4.2% | 0.2 | -6.8% |
| MoM | 67 343 | -6.9% | 1.6% | -0.2 | 79 801 344 | -4.4% | 4.2% | -0.1 | 2.6% |
| YTD | 1 251 599 | -26.0% | 2.2% | -0.6 | 1 307 404 172 | -6.8% | 4.6% | -1 | -7.5% |
| MAT | 1 251 599 | -27.0% | 2.2% | -0.6 | 1 307 404 172 | -7.9% | 4.6% | -1 | -8.7% |
| MEZYM | |||||||||
| WoW | 298 903 | 31.9% | 21.0% | 2.5 | 43 756 183 | 28.9% | 13.8% | 1.3 | 16.4% |
| MoM | 1 051 039 | 14.1% | 18.6% | 0.2 | 155 837 829 | 14.1% | 12.7% | -0.2 | 12.8% |
| YTD | 17 350 407 | -16.4% | 25.4% | -3.7 | 2 644 096 383 | -9.1% | 18.1% | -3.6 | -4.3% |
| MAT | 17 350 407 | -18.2% | 25.4% | -3.7 | 2 644 096 383 | -10.9% | 18.1% | -3.7 | -6.2% |
| MIG 400 | |||||||||
| WoW | 143 611 | -0.6% | 2.6% | 0.2 | 18 155 892 | 1.2% | 2.1% | 0.1 | -7.8% |
| MoM | 640 170 | 14.7% | 2.4% | -0.3 | 78 597 858 | 16.9% | 2.0% | -0.1 | 29.0% |
| YTD | 8 396 280 | -15.1% | 3.2% | -0.6 | 994 198 695 | -11.0% | 2.5% | -0.6 | 0.2% |
| MAT | 8 396 280 | -16.3% | 3.2% | -0.6 | 994 198 695 | -12.2% | 2.5% | -0.6 | -1.5% |
| PROSTAMOL | |||||||||
| WoW | 21 150 | -6.5% | 13.2% | -0.1 | 30 134 726 | -5.6% | 14.5% | 0.2 | -5.8% |
| MoM | 102 828 | 1.0% | 13.4% | -0.7 | 143 857 913 | 2.0% | 14.4% | -0.6 | 6.2% |
| YTD | 1 546 548 | -27.7% | 18.1% | -6.5 | 2 164 877 512 | -19.8% | 19.3% | -7.4 | -1.9% |
| MAT | 1 546 548 | -28.8% | 18.1% | -6.5 | 2 164 877 512 | -20.9% | 19.3% | -7.4 | -3.4% |
| RESPERO MYRTOL | |||||||||
| WoW | 31 902 | -22.5% | 8.3% | -0.8 | 17 210 980 | -21.4% | 9.3% | -0.8 | -14.9% |
| MoM | 164 285 | 61.0% | 8.2% | 1.3 | 85 489 336 | 66.1% | 9.0% | 1.5 | 36.2% |
| YTD | 1 301 516 | 74.3% | 8.3% | 3.3 | 623 558 611 | 80.8% | 8.5% | 3.1 | 6.4% |
| MAT | 1 301 516 | 73.1% | 8.3% | 3.3 | 623 558 611 | 79.6% | 8.5% | 3.2 | 4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 9 846 004 | -25.8% | 4.8% | -1.6 | 2 020 245 630 | -11.8% | 4.7% | -1.1 | -1.1% |
| DEXALGIN | 1 585 574 | -13.8% | 0.6% | -0.1 | 686 697 189 | -2.0% | 1.7% | -0.2 | 0.2% |
| ESPUMISAN (ADULTS) | 4 284 062 | -18.9% | 53.1% | -12.8 | 2 208 618 466 | -8.9% | 58.8% | -11.6 | 0.7% |
| ESPUMISAN BABY | 1 426 141 | -14.3% | 36.9% | -4.4 | 905 578 253 | -6.8% | 50.3% | -5.8 | -4.0% |
| FASTUM | 1 040 568 | -24.9% | 1.1% | -0.4 | 546 361 233 | -14.7% | 2.5% | -0.6 | 0.2% |
| IODOMARIN | 3 293 381 | 4.0% | 20.6% | 0 | 639 996 905 | 8.0% | 9.1% | -0.3 | 4.2% |
| LIOTON | 1 251 599 | -26.0% | 2.2% | -0.6 | 1 307 404 172 | -6.8% | 4.6% | -1 | -7.5% |
| MEZYM | 17 350 407 | -16.4% | 25.4% | -3.7 | 2 644 096 383 | -9.1% | 18.1% | -3.6 | -4.3% |
| MIG 400 | 8 396 280 | -15.1% | 3.2% | -0.6 | 994 198 695 | -11.0% | 2.5% | -0.6 | 0.2% |
| PROSTAMOL | 1 546 548 | -27.7% | 18.1% | -6.5 | 2 164 877 512 | -19.8% | 19.3% | -7.4 | -1.9% |
| RESPERO MYRTOL | 1 301 516 | 74.3% | 8.3% | 3.3 | 623 558 611 | 80.8% | 8.5% | 3.1 | 6.4% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 9 846 004 | -26.3% | 4.8% | -1.5 | 2 020 245 630 | -12.4% | 4.7% | -1 | -2.9% |
| DEXALGIN | 1 585 574 | -15.1% | 0.6% | -0.1 | 686 697 189 | -3.5% | 1.7% | -0.2 | -1.5% |
| ESPUMISAN (ADULTS) | 4 284 062 | -20.1% | 53.1% | -12.8 | 2 208 618 466 | -10.2% | 58.8% | -11.6 | -0.9% |
| ESPUMISAN BABY | 1 426 141 | -15.8% | 36.9% | -4.4 | 905 578 253 | -8.4% | 50.3% | -5.8 | -5.7% |
| FASTUM | 1 040 568 | -26.1% | 1.1% | -0.4 | 546 361 233 | -16.0% | 2.5% | -0.7 | -1.2% |
| IODOMARIN | 3 293 381 | 3.1% | 20.6% | 0.1 | 639 996 905 | 7.0% | 9.1% | -0.3 | 2.8% |
| LIOTON | 1 251 599 | -27.0% | 2.2% | -0.6 | 1 307 404 172 | -7.9% | 4.6% | -1 | -8.7% |
| MEZYM | 17 350 407 | -18.2% | 25.4% | -3.7 | 2 644 096 383 | -10.9% | 18.1% | -3.7 | -6.2% |
| MIG 400 | 8 396 280 | -16.3% | 3.2% | -0.6 | 994 198 695 | -12.2% | 2.5% | -0.6 | -1.5% |
| PROSTAMOL | 1 546 548 | -28.8% | 18.1% | -6.5 | 2 164 877 512 | -20.9% | 19.3% | -7.4 | -3.4% |
| RESPERO MYRTOL | 1 301 516 | 73.1% | 8.3% | 3.3 | 623 558 611 | 79.6% | 8.5% | 3.2 | 4.6% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 154 914 | -18.7% | 2.8% | 0 | 39 698 298 | -15.8% | 3.3% | 0 | -17.7% |
| DEXALGIN | 21 783 | 3.7% | 0.4% | 0 | 10 994 571 | 7.0% | 1.3% | 0.1 | -7.8% |
| ESPUMISAN (ADULTS) | 51 375 | -2.1% | 39.0% | -1.6 | 31 278 078 | -0.1% | 48.2% | -0.9 | 2.0% |
| ESPUMISAN BABY | 21 157 | -3.2% | 30.6% | -0.5 | 15 444 761 | -2.3% | 46.1% | -0.6 | -1.8% |
| FASTUM | 15 047 | 4.8% | 0.9% | 0.1 | 8 573 738 | 5.9% | 2.3% | 0.2 | -6.9% |
| IODOMARIN | 57 914 | -10.2% | 21.6% | -0.4 | 10 670 511 | -9.6% | 8.2% | -0.3 | -8.8% |
| LIOTON | 14 285 | -1.1% | 1.6% | 0.1 | 17 298 730 | 2.6% | 4.2% | 0.2 | -6.8% |
| MEZYM | 298 903 | 31.9% | 21.0% | 2.5 | 43 756 183 | 28.9% | 13.8% | 1.3 | 16.4% |
| MIG 400 | 143 611 | -0.6% | 2.6% | 0.2 | 18 155 892 | 1.2% | 2.1% | 0.1 | -7.8% |
| PROSTAMOL | 21 150 | -6.5% | 13.2% | -0.1 | 30 134 726 | -5.6% | 14.5% | 0.2 | -5.8% |
| RESPERO MYRTOL | 31 902 | -22.5% | 8.3% | -0.8 | 17 210 980 | -21.4% | 9.3% | -0.8 | -14.9% |
| Brand | Volume, packs | Change, % | MS Volume | Change, p.p. | Value, rur | Change, % | MS Value | Change, p.p. | Cat. Volume Change, % |
|---|---|---|---|---|---|---|---|---|---|
| BROMHEXINE B-CH | 881 320 | 45.7% | 3.1% | -0.2 | 211 916 362 | 53.0% | 3.4% | 0 | 53.3% |
| DEXALGIN | 86 814 | 27.7% | 0.3% | 0 | 42 243 433 | 24.6% | 1.1% | 0 | 29.0% |
| ESPUMISAN (ADULTS) | 241 465 | 0.3% | 41.0% | -0.3 | 141 226 638 | 7.8% | 48.9% | 0.6 | 1.0% |
| ESPUMISAN BABY | 101 055 | -2.2% | 31.5% | -2.3 | 71 889 362 | 3.5% | 46.8% | -0.7 | 5.1% |
| FASTUM | 67 210 | -6.8% | 0.8% | -0.1 | 38 269 832 | -6.6% | 2.2% | -0.2 | 2.4% |
| IODOMARIN | 292 263 | -2.5% | 21.9% | -1.3 | 53 688 884 | -3.2% | 8.6% | -1.2 | 3.2% |
| LIOTON | 67 343 | -6.9% | 1.6% | -0.2 | 79 801 344 | -4.4% | 4.2% | -0.1 | 2.6% |
| MEZYM | 1 051 039 | 14.1% | 18.6% | 0.2 | 155 837 829 | 14.1% | 12.7% | -0.2 | 12.8% |
| MIG 400 | 640 170 | 14.7% | 2.4% | -0.3 | 78 597 858 | 16.9% | 2.0% | -0.1 | 29.0% |
| PROSTAMOL | 102 828 | 1.0% | 13.4% | -0.7 | 143 857 913 | 2.0% | 14.4% | -0.6 | 6.2% |
| RESPERO MYRTOL | 164 285 | 61.0% | 8.2% | 1.3 | 85 489 336 | 66.1% | 9.0% | 1.5 | 36.2% |
ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the* last full month* and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
## [1] "BROMHEXINE B-CH"## [1] "BROMHEXINE B-CH COATED TABLETS 8 MG #25"## [1] "BROMHEXINE B-CH SOL ORAL 4 MG/5 ML 60 ML #1"## [1] "ESPUMISAN (ADULTS)"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #25"## [1] "ESPUMISAN (ADULTS) CAPS 40 MG #50"## [1] "ESPUMISAN (ADULTS) EXTRA GRAN 125 MG #14"## [1] "ESPUMISAN (ADULTS) L EMULS ORAL 40 MG 30 ML #1"## [1] "ESPUMISAN BABY"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 30 ML #1"## [1] "ESPUMISAN BABY ORAL DROPS 100 MG/ML 50 ML #1"## [1] "FASTUM"## [1] "FASTUM GEL FOR EXT USE 2,5% 100 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 30 G #1"## [1] "FASTUM GEL FOR EXT USE 2,5% 50 G #1"## [1] "LIOTON"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 100 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 30 G #1"## [1] "LIOTON 1000 GEL FOR EXT USE 1000 IU/G 50 G #1"## [1] "MEZYM"## [1] "MEZYM 20000 INTESTINAL-SOLUBLE COATED TABLETS 20000 IU #20"## [1] "MEZYM FORTE COATED TABLETS #20"## [1] "MEZYM FORTE COATED TABLETS #80"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #20"## [1] "MEZYM NEO 10000 CAPS ENTEROSOLUB 10000 IU #50"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #20"## [1] "MEZYM NEO 25000 CAPS ENTEROSOLUB 25000 IU #50"## [1] "MEZYM PRO INTESTINAL-SOLUBLE COATED TABLETS 10000 ED #20"## [1] "DEXALGIN"## [1] "DEXALGIN 25 COATED TABLETS 25 MG #10"## [1] "MIG 400"## [1] "MIG 400 COATED TABLETS 400 MG #10"## [1] "MIG 400 COATED TABLETS 400 MG #20"## [1] "PROSTAMOL"## [1] "PROSTAMOL UNO CAPS 320 MG #30"## [1] "PROSTAMOL UNO CAPS 320 MG #60"## [1] "PROSTAMOL UNO CAPS 320 MG #90"## [1] "IODOMARIN"## [1] "IODOMARIN 100 TABS 100 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #100"## [1] "IODOMARIN 200 TABS 200 MCG #50"## [1] "IODOMARIN FOR THE FUTURE MOTHER TABLETS 140 MG #30"## [1] "RESPERO MYRTOL"## [1] "RESPERO MYRTOL CAPS ENTEROSOLUB 120 MG #20"## [1] "RESPERO MYRTOL FORTE CAPS ENTEROSOLUB 300 MG #20"[RUS] ОБОЗНАЧЕНИЯ
WoW - Week Over Week - показатели для сравнения результатов текущей и предыдущей недели
MoM - Month Over Month - показатели для сравнения результатов последнего полного месяца и предыдущего полного месяца
YTD - Year to Date - показатели для сравнения результатов за период времени, начинающийся с первого дня текущего календарного года до текущей даты с результатами за сопоставимый период прошлого года
MAT - Moving Annual Total - показатели для сравнения результатов за период 12 месяцев, с датой окончания на последней доступной неделе, с результатами за сопоставимый период прошлого года
MS - Market Share - Доля рынка = (Продажи бренда / Продажи категории)*100%
Change, % = (Продажи бренда за последний период / Продажи бренда за предыдущий период - 1)*100%
Change, p.p. = Доля бренда на рынке за последний период - Доля бренда на рынке за предыдущий период (выражается в процентных пунктах)
Cat. Volume Change, % = (Продажи категории в упаковках за последний период / Продажи категории в упаковках за предыдущий период - 1)*100%
Каждая категория собрана специально для каждого бренда и включает в себя бренд и его конкурентов
Список конкурентов можно найти в разделе "MS of competitors" в блоке каждого бренда
[ENG] ABBREVIATIONS
WoW - Week Over Week - indicators for comparing the results of the current and previous week
MoM - Month Over Month - indicators for comparing the results of the last full month and previous full month
YTD - Year to Date - indicators for comparing the results of the period of time beginning the first day of the current calendar year up to the current date with the results of the comparable period last year
MAT - Moving Annual Total - indicators for comparing the results of the period, being 12 month period ending on the last week with the results of the comparable period last year
MS - Market Share - (Brand Sales / Category Sales)*100%
Change, % = (Brand Sales of the last period / Brand Sales of the previous period - 1)*100%
Change, p.p. = Brand Market Share of the last period - Brand Market Share of the previous period (expressed in percentage points)
Cat. Volume Change, % = (Category Sales in packs of the last period / Category Sales in packs of the previous period - 1)*100%
Each category is created specifically for each brand and includes the brand and its competitors
The list of competitors can be found in the subsection "MS of competitors" in sections for each brand
DATA SOURCES:
DSM: Sales
Palomars: TRPs
MI: Fact Digital Costs
MI Estimated Costs: TV costs